Activation of 5-HT3 receptors in the medulla oblongata is involved in the phasic control of urinary bladder. (1st November 2022)

• Record Type: Journal Article
• Authors: Lopes, Fábio I.; do Vale, Bárbara; Cafarchio, Eduardo M.; Dsouki, Nuha A.; Aronsson, Patrik; Sato, Monica A.
• Is Part Of: Neuroscience letters. Volume 790(2022)
• Publication Date: 2022-11-01
• Subjects: Serotonin -- 4th ventricle -- 5-HT3 receptors -- Urinary bladder; Neurology -- Periodicals; Neurology -- Periodicals; Research -- Periodicals; Neurologie -- Périodiques; Neuroanatomie -- Périodiques; Neuropharmacologie -- Périodiques; Neurophysiologie -- Périodiques; Neurology; Periodicals; Electronic journals; 617.48
• DOI: 10.1016/j.neulet.2022.136886
• Languages: English
• ISSNs: 0304-3940

Abstract

Highlights: The activation of 5-HT3 receptors in medullary areas increases the intravesical pressure. 5-HT3 receptors are involved in the phasic control of urinary bladder. 5-HT3 receptors in the medulla oblongata are involved in the pathways of the tonic control of the cardiovascular system. Abstract: The control of micturition depends on reflex mechanisms, however, it undergoes modulation from cortex, pons and medullary areas. This study investigated if the activation of 5-HT3 receptors in the medulla influences the urinary bladder (UB) regulation in rats. Isoflurane female Wistar rats were submitted to catheterization of the femoral artery and vein for mean arterial pressure (MAP) and heart rate (HR) recordings and injection of drugs, respectively. The UB was cannulated for intravesical pressure (IP) measurement. The Doppler flow probe was placed around the left renal artery for renal conductance (RC) recordings. Phenylbiguanide (PB) and granisetron (GN) were injected into the 4th brain ventricle in rats with guide cannulas implanted 5 days prior to the experiments; or PB and GN were randomly injected intravenously or applied topically ( in situ ) on the UB. PB injection into 4th V significantly increased IP (68.67 ± 11.70%) and decreased MAP (−29 ± 6 mmHg) compared to saline (0.34 ± 0.64% and −2 ± 2 mmHg), with no changes in the HR and RC. GN injection into the 4th V did not significantly change the IP and RC compared to saline, nevertheless, significantly increased MAP (25 ± 4 mmHg) and heart rate (36 ± 9 bpm) compared to saline. Intravenous PB and GN only produced cardiovascular effects, whilst PB but not GN in situ on the UB evoked increase in IP (111.60 ± 30.36%). Therefore, the activation of 5HT-3 receptors in medullary areas increases the intravesical pressure and these receptors are involved in the phasic control of UB. In contrast, 5-HT3 receptors in the medulla oblongata are involved in the pathways of the tonic control of the cardiovascular system. The activation of 5-HT3 receptors in the bladder cause increase in intravesical pressure and this regulation seem to be under phasic control as the blockade of such receptors elicits no changes in baseline intravesical pressure.